ATA921778A - Verfahren zur herstellung von neuen derivaten der hydroxycarbonylphosphonsaeure, sowie von deren salzen und optpischen antipoden - Google Patents

Verfahren zur herstellung von neuen derivaten der hydroxycarbonylphosphonsaeure, sowie von deren salzen und optpischen antipoden

Info

Publication number
ATA921778A
ATA921778A AT0921778A AT921778A ATA921778A AT A921778 A ATA921778 A AT A921778A AT 0921778 A AT0921778 A AT 0921778A AT 921778 A AT921778 A AT 921778A AT A921778 A ATA921778 A AT A921778A
Authority
AT
Austria
Prior art keywords
salts
producing new
new derivatives
optical antipodes
hydroxycarbonylphosphonic acid
Prior art date
Application number
AT0921778A
Other languages
English (en)
Other versions
AT369017B (de
Inventor
Ake John Erik Helgstrand
Karl Nils-Gunnar Johansson
Alfons Misiorny
Jan-Olof Noren
Goeran Bertil Stening
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of ATA921778A publication Critical patent/ATA921778A/de
Application granted granted Critical
Publication of AT369017B publication Critical patent/AT369017B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4062—Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
    • C07F9/4065—Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0921778A 1977-12-22 1978-12-22 Verfahren zur herstellung von neuen derivaten der hydroxycarbonylphosphonsaeure, sowie von deren salzen und optischen antipoden AT369017B (de)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB5358377 1977-12-22
GB5358177 1977-12-22
GB5358277 1977-12-22
GB5358077 1977-12-22
GB7828552 1978-07-03
GB7828553 1978-07-03
GB7828548 1978-07-03
GB7828555 1978-07-03

Publications (2)

Publication Number Publication Date
ATA921778A true ATA921778A (de) 1982-04-15
AT369017B AT369017B (de) 1982-11-25

Family

ID=27571200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0921778A AT369017B (de) 1977-12-22 1978-12-22 Verfahren zur herstellung von neuen derivaten der hydroxycarbonylphosphonsaeure, sowie von deren salzen und optischen antipoden

Country Status (14)

Country Link
US (4) US4372894A (de)
EP (2) EP0003275B1 (de)
JP (2) JPS54109951A (de)
AT (1) AT369017B (de)
AU (1) AU530031B2 (de)
CA (2) CA1140049A (de)
DE (2) DE2861045D1 (de)
DK (2) DK148631C (de)
FI (2) FI65438C (de)
HK (1) HK33584A (de)
IE (1) IE48011B1 (de)
MY (1) MY8500058A (de)
NO (2) NO154751C (de)
SG (1) SG82383G (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5166386A (en) * 1989-09-18 1992-11-24 E. R. Squibb & Sons, Inc. Process of making isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5025003A (en) * 1989-09-18 1991-06-18 E. R. Squibb & Sons, Inc. Isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US5132414A (en) * 1990-05-10 1992-07-21 Dana-Farber Cancer Institute, Inc. Dideoxynucleoside-5'-phosphonoformic acid compounds
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
US6096730A (en) * 1997-07-24 2000-08-01 University Of Kentucky Research Foundation Phosphonated agents and their antiangiogenic and antitumorigenic use
US5869469A (en) * 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis
NZ550116A (en) * 1997-08-18 2008-03-28 Neurochem Int Ltd Phosphono-carboxylate compounds for treating amyloidosis
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DK1054664T3 (da) * 1998-02-11 2012-11-05 Bhi Ltd Partnership Fremgangsmåde til modulering af makrofagaktivering
US6329356B1 (en) 1998-04-10 2001-12-11 Neurochem, Inc. Phosphono-carboxylate compounds for treating amyloidosis
US6310073B1 (en) * 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
CA2369997C (en) * 1999-04-28 2009-11-17 Queen's University At Kingston Compositions and methods for treating amyloidosis
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
BR0016652A (pt) * 1999-12-23 2002-11-19 Neurochem Inc Métodos para inibir angiopatia amilóide cerebral, para tratar um estado de doença caracterizado por angiopatia amilóide cerebral em um indivìduo, e para diagnosticar angiopatia amilóide cerebral em um indivìduo
AU2003215826A1 (en) * 2002-04-01 2003-10-13 Pfizer Inc. Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
DOP2003000641A (es) * 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) * 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
US20040214178A1 (en) * 2003-04-24 2004-10-28 Agouron Pharmaceuticals, Inc. Reporter-selectable Hepatitis C virus replicon
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
ES2361845T3 (es) * 2004-08-18 2011-06-22 Pfizer, Inc. Inhibidores de arn polimerasa dependiente del arn del virus de la hepatitis c y composiciones y tratamientos que utilizan los mismos.
ITMI20041822A1 (it) * 2004-09-24 2004-12-24 Pharmaproducts Uk Ltd "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
AU2005310979A1 (en) * 2004-11-16 2006-06-08 Bellus Health (International) Limited Compounds for the treatment of CNS and amyloid associated diseases
EP1836161B1 (de) 2004-12-22 2016-07-20 BHI Limited Partnership Verfahren und zusammensetzungen zur behandlung von amyloidassoziierten krankheiten
ATE481094T1 (de) * 2005-12-22 2010-10-15 Kiacta Sarl Behandlung von diabetischer nephropathie
SI2089417T1 (sl) 2006-10-12 2015-04-30 Bhi Limited Partnership Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline
CA2673022A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
DE102012103717A1 (de) * 2012-04-27 2013-11-14 Westfälische Wilhelms-Universität Münster Arzneimittel zur Behandlung von Tumorerkrankungen
US10374256B2 (en) * 2013-12-19 2019-08-06 Ube Industries, Ltd. Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
CN109400645A (zh) * 2017-08-18 2019-03-01 四川海思科制药有限公司 一种磷酸衍生物及制备方法和用途
KR20260115964A (ko) * 2023-11-17 2026-07-27 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 주니어 유니버시티 전구약물 모이어티 및 이를 포함하는 화합물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155597A (en) * 1961-06-23 1964-11-03 Monsanto Co Extractive separation process
US3846512A (en) * 1968-05-24 1974-11-05 Du Pont Carbamoylphosphonates
US3997544A (en) * 1968-05-24 1976-12-14 E. I. Du Pont De Nemours And Company Plant growth regulant carbamoylphosphonates
CH513590A (de) 1968-05-24 1971-10-15 Du Pont Carbamoylphosphonat enthaltender Pflanzenwachstumsregler
US3533995A (en) * 1968-08-27 1970-10-13 Fmc Corp Heat stabilization of polyester resin with alkyl dialkoxyphosphinyl formate
GB1317768A (en) 1969-08-14 1973-05-23 Du Pont Plant growth regulants
US3849102A (en) * 1969-08-14 1974-11-19 Du Pont Plant growth regulant method
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3943201A (en) * 1973-07-23 1976-03-09 E. I. Du Pont De Nemours And Comapny Alkoxy carboxycarbonylphosphonic acid esters
HU171255B (hu) 1973-07-23 1977-12-28 Du Pont Kompozicii dlja regulirovki rosta rastenijj
US4017297A (en) * 1975-08-29 1977-04-12 E. I. Du Pont De Nemours And Company Phosphonates for the control of bindweed
US4052439A (en) * 1976-04-30 1977-10-04 Abbott Laboratories Carboxylic esters of phosphonoacetic acid
US4092412A (en) * 1976-04-30 1978-05-30 Abbott Laboratories Treatment of herpes simplex infections
CA1069526A (en) * 1976-04-30 1980-01-08 Thomas R. Herrin Phosphorus esters of phosphonoacetic acid
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid

Also Published As

Publication number Publication date
DK148631C (da) 1986-03-03
FI783931A7 (fi) 1979-06-23
NO154751C (no) 1986-12-17
JPS6254118B2 (de) 1987-11-13
AU4268278A (en) 1979-06-28
FI65438B (fi) 1984-01-31
NO784331L (no) 1979-06-25
US4536400A (en) 1985-08-20
JPS6330885B2 (de) 1988-06-21
US4372894A (en) 1983-02-08
IE48011B1 (en) 1984-09-05
NO784330L (no) 1979-06-25
FI783932A7 (fi) 1979-06-23
DE2861729D1 (en) 1982-05-19
EP0003275B1 (de) 1981-09-02
DK148631B (da) 1985-08-19
IE782493L (en) 1979-06-22
AT369017B (de) 1982-11-25
HK33584A (en) 1984-04-27
EP0003007A3 (en) 1979-08-08
JPS54109951A (en) 1979-08-29
DK148632B (da) 1985-08-19
JPS54106431A (en) 1979-08-21
DK564278A (da) 1979-06-23
SG82383G (en) 1985-03-08
MY8500058A (en) 1985-12-31
FI65438C (fi) 1984-05-10
NO156611C (no) 1987-10-21
CA1140049A (en) 1983-01-25
NO156611B (no) 1987-07-13
CA1144937A (en) 1983-04-19
NO154751B (no) 1986-09-08
US4386081A (en) 1983-05-31
DE2861045D1 (en) 1981-11-26
FI68626C (fi) 1985-10-10
AU530031B2 (en) 1983-06-30
DK564178A (da) 1979-06-23
EP0003275A1 (de) 1979-08-08
DK148632C (da) 1986-03-03
US4591583A (en) 1986-05-27
FI68626B (fi) 1985-06-28
EP0003007B1 (de) 1982-04-07
EP0003007A2 (de) 1979-07-11

Similar Documents

Publication Publication Date Title
AT369017B (de) Verfahren zur herstellung von neuen derivaten der hydroxycarbonylphosphonsaeure, sowie von deren salzen und optischen antipoden
AT365576B (de) Verfahren zur herstellung von neuen n-alkylpiperidinderivaten und deren saeureadditionssalzen
AT358023B (de) Verfahren zur herstellung von neuen substi- tuierten 1,1,2-triphenylalken-derivaten und von deren saeureadditionssalzen
AT363457B (de) Verfahren zur herstellung von neuen substituierten 1-(3-aminosulfonylphenyl)-2-alkylaminoaethanolen und deren saeureadditionssalzen
AT361937B (de) Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen
AT365184B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren saeureadditionssalzen
AT359522B (de) Verfahren zur herstellung von neuen 6-amino- alkylaminouracilen sowie deren saeureadditions- salzen
AT366666B (de) Verfahren zur herstellung von neuen amidinosulfon- saeurederivaten und von deren salzen
AT360972B (de) Verfahren zur herstellung von neuen amino- benzoesaeureamiden und deren salzen
AT363923B (de) Verfahren zur herstellung von neuen 8-amino-alkyltetracyclononanen und von deren saeureadditionssalzen
AT361904B (de) Verfahren zur herstellung von neuen 3-anilino- aethylamino-2-hydroxy-1-phenoxypropanen sowie deren saeureadditionssalzen
AT359481B (de) Verfahren zur herstellung von neuen antiin- flammatorischen 1-phenyl-2-aminoaethanol- derivaten und von deren saeureadditionssalzen
AT361482B (de) Verfahren zur herstellung von neuen 4-phenyl-8- -amino-tetrahydroisochinolinen und ihren physioligisch unbedenklichen saeureadditions- salzen
AT360033B (de) Verfahren zur herstellung von neuen tetrahydro- -s-triazinthionen und deren saeure- additionssalzen
ATA559778A (de) Verfahren zur herstellung von neuen 1,2- -benzisothiazolen und deren saeureadditions- salzen
ATA86579A (de) Verfahren zur herstellung von neuen cis-4aphenylisochinolinderivaten und ihren saeureadditionssalzen
AT369740B (de) Verfahren zur herstellung von neuen thiodibenzthiepinen und deren saeureadditionssalzen
ATA162476A (de) Verfahren zur herstellung von neuen phenoxy- phenylbuttersaeure-derivaten sowie von ihren salzen
AT366679B (de) Verfahren zur herstellung von neuen naphthalinderivaten und von deren salzen, racematen und enantiomeren
ATA557880A (de) Verfahren zur herstellung von neuen diaminothiocyanato-benzol-derivate sowie von deren salzen
ATA398778A (de) Verfahren zur herstellung von neuen 2acetoxybenzoesaeureestern von 4-alkyl-3,5-dioxopyrazolidinderivaten und ihren saeureadditionsalzen
ATA59280A (de) Verfahren zur herstellung von neuen 3-anilinoaethylamino-2-hydroxy-1-phenoxypropanen sowie deren saeureadditionssalzen
AT364365B (de) Verfahren zur herstellung von neuen substituierten octahydropyrazinopyrimidinonen und deren saeureadditionssalzen
ATA148580A (de) Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen
AT365587B (de) Verfahren zur herstellung von neuen 2-methyl-2phenoxypropionsaeurederivaten und deren physiolo- gisch vertraeglichen salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee